BioNexus Gene Lab Corp. (BGLC)

Last Closing Price: 4.29 (2025-05-30)

Expense Ratio (Quarterly)

Expense Ratio: A measure of profitability used by an insurance company to indicate how well it is performing in its daily operations. The expense ratio is calculated by taking the operating expenses and then dividing them by earned premium. Calculated as: (Total Operating Expenses - Underwriting Losses Total) / Net Premiums Earned

BioNexus Gene Lab Corp. (BGLC) Expense Ratio data is not available.

Figures for fiscal quarter ending 2025-03-31
Income Statement Financials
$2.14M
$-0.62M
$1.79M
$0.34M
$2.76M
$-0.62M
$-0.00M
$-0.62M
$-0.62M
$-0.62M
$-0.62M
$-0.62M
$-0.62M
$-0.59M
$-0.55M
17.97M
17.97M
$-0.04
$-0.04
Balance Sheet Financials
$6.54M
$1.52M
$2.94M
$9.48M
$1.56M
--
$0.15M
$1.71M
$7.77M
$7.77M
$7.77M
17.97M
Cash Flow Statement Financials
$-0.82M
$-0.02M
$-0.00M
$2.89M
$2.09M
$-0.80M
--
--
--
Fundamental Metrics & Ratios
4.19
--
--
--
0.01
16.07%
-28.94%
-27.83%
--
-29.17%
-29.17%
$-0.83M
--
Expense Ratio
--
--
0.23
1.52
1.21
74.45
-8.02%
-8.02%
-6.58%
-8.02%
$0.43
$-0.05
$-0.05